The Royalty Rate Report 2012: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector

The Royalty Rate Report 2012: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector


March 19, 2012
202 Pages - SKU: PHV3815907
License type:
Single User Annual Subscription       US $8,005.00

The 2012 Report presents:

  • Major new case studies
  • Full, new data and analysis based on data from the premier agreements database, PharmaDeals® v4, and other sources
  • Topics including Royalties and Deal Structures, Sales Milestones, Tiered Royalties, Alternative Structures, Technology Deals, Deal Creativity, Upfront Payments and Milestones, Royalties and IP Values and Market Cap, and Royalty Rates by Phase and Indication.
  • Data and analysis of a recent major survey undertaken by PharmaVentures about royalties and changes in deal making over the last 5 years
  • A glossary, and a wealth of figures and tables
The Report updates previous editions with a review of methods for calculating royalties, including topics such as research and development costs, benchmarking, transfer pricing, the basics of eNPV and NPV calculation, cash flows, relevant costs, risk and cash burn.